JP2004504842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004504842A5 JP2004504842A5 JP2002516309A JP2002516309A JP2004504842A5 JP 2004504842 A5 JP2004504842 A5 JP 2004504842A5 JP 2002516309 A JP2002516309 A JP 2002516309A JP 2002516309 A JP2002516309 A JP 2002516309A JP 2004504842 A5 JP2004504842 A5 JP 2004504842A5
- Authority
- JP
- Japan
- Prior art keywords
- tif
- molecule
- modulator
- cell
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62661700A | 2000-07-27 | 2000-07-27 | |
| PCT/US2001/020485 WO2002010393A2 (en) | 2000-07-27 | 2001-06-27 | Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004504842A JP2004504842A (ja) | 2004-02-19 |
| JP2004504842A5 true JP2004504842A5 (https=) | 2005-04-14 |
| JP4113773B2 JP4113773B2 (ja) | 2008-07-09 |
Family
ID=24511131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002516309A Expired - Fee Related JP4113773B2 (ja) | 2000-07-27 | 2001-06-27 | Ｔ細胞誘導性因子またはインターロイキン２１をコードする単離された核酸分子、それらがコードするタンパク質およびその用途 |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1305419B1 (https=) |
| JP (1) | JP4113773B2 (https=) |
| CN (3) | CN100497628C (https=) |
| AT (2) | ATE365801T1 (https=) |
| AU (1) | AU7303301A (https=) |
| CA (1) | CA2416820A1 (https=) |
| DE (2) | DE60129137D1 (https=) |
| ES (1) | ES2349312T3 (https=) |
| WO (1) | WO2002010393A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7307161B1 (en) | 1999-04-28 | 2007-12-11 | Genetics Institute, Llc | Human Gil-19/AE289 polynucleotides |
| US6939545B2 (en) | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
| US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
| US20030023033A1 (en) * | 2001-07-26 | 2003-01-30 | Laure Dumoutier | Novel class II cytokine receptors and uses thereof |
| US20030012788A1 (en) | 2000-07-27 | 2003-01-16 | Jean-Christophe Renauld | Method for influencing kinase pathways with IL-22 |
| US20060083713A1 (en) * | 2000-10-13 | 2006-04-20 | Eli Lilly And Company | Methods of using a human il-17 related polypeptide to treat disease |
| US7638604B2 (en) | 2001-02-23 | 2009-12-29 | Genetics Institute, Llc | Monoclonal antibodies against interleukin-22 |
| EP1546358A4 (en) | 2002-03-22 | 2006-06-07 | Zymogenetics Inc | ANTI-IL-TIF ANTIBODIES AND METHOD FOR USE ON INFLAMMATION |
| WO2004003156A2 (en) | 2002-07-01 | 2004-01-08 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Il-21 as a regulator of immunoglobin production |
| EP1562587A4 (en) * | 2002-09-11 | 2006-07-19 | Genentech Inc | NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF IMMUNOMOTICS |
| PL376118A1 (en) * | 2002-10-11 | 2005-12-12 | Novo Nordisk A/S | Treatment of allergic conditions by use of il 21 |
| KR20050065590A (ko) * | 2002-10-11 | 2005-06-29 | 노보 노르디스크 에이/에스 | Il 21을 이용한 알레르기 상태의 치료법 |
| ES2354693T3 (es) * | 2003-06-23 | 2011-03-17 | Genetics Institute, Llc | Anticuerpos contra interleucina-22 y usos para ellos. |
| EP1954719A2 (en) | 2005-12-02 | 2008-08-13 | Genentech Inc. | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r |
| TWI417301B (zh) | 2006-02-21 | 2013-12-01 | Wyeth Corp | 對抗人類介白素-２２（ｉｌ-２２）之抗體及其用途 |
| TW200744634A (en) | 2006-02-21 | 2007-12-16 | Wyeth Corp | Methods of using antibodies against human IL-22 |
| IT1404858B1 (it) | 2011-02-21 | 2013-12-09 | Milano Politecnico | Supporto anti-sismico. |
| US20240026014A1 (en) * | 2020-08-05 | 2024-01-25 | Synthekine, Inc. | Compositions and methods related to receptor pairings |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843697A (en) | 1996-07-17 | 1998-12-01 | University Of Medicine And Dentistry Of New Jersey | Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein |
| DE19848683B4 (de) | 1998-10-22 | 2004-05-06 | Basf Ag | Verbundschichtplatte |
| EP1131333B1 (en) * | 1998-10-26 | 2010-06-02 | Wyeth a Corporation of the State of Delaware | ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
| BR0010097A (pt) * | 1999-04-28 | 2002-02-13 | Genetics Inst | Polinucleotìdeo isolado; célula hospedeira; processo para a produção de uma proteìna codificada pelo polinucleotìdeo; proteìna; composição; e; anticorpo |
| AU5047600A (en) * | 1999-05-27 | 2000-12-18 | Schering Corporation | Mammalian interleukin-10 homologs: il-d110 and il-d210 |
| US6897292B2 (en) * | 1999-12-03 | 2005-05-24 | Zymogenetics, Inc. | Human cytokine receptor |
-
2001
- 2001-06-27 DE DE60129137T patent/DE60129137D1/de not_active Expired - Lifetime
- 2001-06-27 AU AU7303301A patent/AU7303301A/xx not_active Withdrawn
- 2001-06-27 WO PCT/US2001/020485 patent/WO2002010393A2/en not_active Ceased
- 2001-06-27 AT AT01952260T patent/ATE365801T1/de not_active IP Right Cessation
- 2001-06-27 EP EP01952260A patent/EP1305419B1/en not_active Expired - Lifetime
- 2001-06-27 ES ES07002409T patent/ES2349312T3/es not_active Expired - Lifetime
- 2001-06-27 EP EP07002409A patent/EP1806404B1/en not_active Expired - Lifetime
- 2001-06-27 AT AT07002409T patent/ATE478148T1/de not_active IP Right Cessation
- 2001-06-27 CN CNB2005101169978A patent/CN100497628C/zh not_active Expired - Fee Related
- 2001-06-27 CN CNA2008101764854A patent/CN101423551A/zh active Pending
- 2001-06-27 DE DE60142861T patent/DE60142861D1/de not_active Expired - Lifetime
- 2001-06-27 CA CA002416820A patent/CA2416820A1/en not_active Abandoned
- 2001-06-27 CN CNB018131255A patent/CN100448994C/zh not_active Expired - Fee Related
- 2001-06-27 JP JP2002516309A patent/JP4113773B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004504842A5 (https=) | ||
| Marcovina et al. | Development of an LC-MS/MS proposed candidate reference method for the standardization of analytical methods to measure lipoprotein (a) | |
| Arndt et al. | Bioelectrical impedance assay to monitor changes in cell shape during apoptosis | |
| Amacher | The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity | |
| Rockey et al. | Smooth muscle α actin (Acta2) and myofibroblast function during hepatic wound healing | |
| Cummings et al. | Biomarker method validation in anticancer drug development | |
| Kongsuphol et al. | EIS-based biosensor for ultra-sensitive detection of TNF-α from non-diluted human serum | |
| EP1200832B1 (en) | Annexins and autoantibodies used as markers for lung cancer and oesophageal cancer | |
| Suprun et al. | Electrochemical nanobiosensor for express diagnosis of acute myocardial infarction in undiluted plasma | |
| Limbut et al. | A reusable capacitive immunosensor for carcinoembryonic antigen (CEA) detection using thiourea modified gold electrode | |
| CA2480466A1 (en) | Detection and/or monitoring of synuclein-related diseases | |
| Stobiecka et al. | Piezometric biosensors for anti-apoptotic protein survivin based on buried positive-potential barrier and immobilized monoclonal antibodies | |
| DE60317422D1 (de) | Mediator-stabilisierende Verbindung und Methoden zur Verwendung zur Detektion elektrochemischer Analyte | |
| Valverde et al. | Electrochemical immunoplatform to improve the reliability of breast cancer diagnosis through the simultaneous determination of RANKL and TNF in serum | |
| Cheng et al. | Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes | |
| Pohanka | Quartz crystal microbalance biosensor for the detection of procalcitonin | |
| Shizu et al. | The influence of the long-term chemical activation of the nuclear receptor pregnane X receptor (PXR) on liver carcinogenesis in mice | |
| WO2019023764A1 (pt) | Dispositivo para detecção do biomarcador adami 0 para o diagnostico da doença de alzheimer, método de aplicação do referido dispositivo, uso do dito dispositivo para diagnóstico da doemça de alzheimer, método de aplicação de elisa para diagnóstico da doença de alzheimer | |
| Uppal et al. | Comparative analysis of aptamers binding to SARS-CoV-2 N protein using capillary electrophoresis and bio-layer interferometry | |
| Hiyoshi et al. | Prognostic significance of IMMT expression in surgically‐resected lung adenocarcinoma | |
| Athey et al. | A study of enzyme‐catalyzed product deposition on planar gold electrodes using electrical impedance measurement | |
| Wu et al. | SPLUNC1 is a negative regulator of the Orai1 Ca2+ channel | |
| HUP9800225A2 (hu) | Eljárás és vegyületek analitok meghatározására remanenciaméréssel és ezek alkalmazásai | |
| Kirschberg et al. | ATP synthase modulation leads to an increase of spare respiratory capacity in HPV associated cancers | |
| Wang et al. | Electrochemical immunoassay for α-fetoprotein through a phenylboronic acid monolayer on gold |